Hap Trading, LLC Eli Lilly & CO Call Options Transaction History

Hap Trading, LLC

$872 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $926,568 - $1.15 Million	-1,200 Reduced 6.22%	18,100 $1.53 Billion
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $5.07 Million - $6.36 Million	7,000 Added 56.91%	19,300 $2.43 Billion
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $3.49 Million - $4.67 Million	-5,900 Reduced 32.42%	12,300 $967 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $1.16 Million - $1.36 Million	-2,200 Reduced 10.78%	18,200 $462 Million
Q3 2023 Nov 09, 2023	SELL	$434.7 - $599.3 $8.26 Million - $11.4 Million	-19,000 Reduced 48.22%	20,400 $11 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $13.8 Million - $18.5 Million	39,400 New	39,400 $18.5 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $2.15 Million - $2.51 Million	-6,700 Reduced 33.84%	13,100 $505,000
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $830,144 - $946,036	-2,800 Reduced 12.39%	19,800 $451,000
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $2.48 Million - $2.91 Million	8,900 Added 64.96%	22,600 $981,000
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $586,725 - $729,150	2,500 Added 22.32%	13,700 $539,000
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $764,490 - $948,736	-3,400 Reduced 23.29%	11,200 $494,000
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $1.31 Million - $1.61 Million	-5,900 Reduced 28.78%	14,600 $426,000
Q2 2021 Aug 11, 2021	SELL	$180.55 - $233.54 $306,935 - $397,018	-1,700 Reduced 7.66%	20,500 $711,000
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $936,624 - $1.21 Million	-5,700 Reduced 20.43%	22,200 $356,000
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $1.92 Million - $2.54 Million	14,700 Added 111.36%	27,900 $405,000
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $87,732 - $101,478	600 Added 4.76%	13,200 $101,000
Q2 2020 Aug 10, 2020	SELL	$136.42 - $164.18 $163,703 - $197,016	-1,200 Reduced 8.7%	12,600 $195,000
Q1 2020 May 08, 2020	SELL	$119.05 - $147.35 $80.5 Million - $99.7 Million	-676,400 Reduced 98.0%	13,800 $125,000
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $37.1 Million - $43.7 Million	333,500 Added 93.5%	690,200 $10.4 Million
Q4 2018 Feb 12, 2019	BUY	$105.9 - $118.64 $37.8 Million - $42.3 Million	356,700 New	356,700 $3.45 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$73 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$55.6 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$49.6 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$38.7 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$25.5 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account